➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
McKesson
Baxter
Colorcon
AstraZeneca

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: vandetanib


Email this page to a colleague

« Back to Dashboard

Vandetanib

CASRN: 443913-73-3

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
AstraZeneca
Dow
Johnson and Johnson
Mallinckrodt